Engineers Gate Manager LP Corcept Therapeutics Inc Transaction History

Engineers Gate Manager LP

$4.27 Billion
Q2 2024

A detailed history of Engineers Gate Manager LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 153,389 shares of CORT stock, worth $7.1 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

153,389

Previous 206,751 25.81%

Holding current value

$7.1 Million

Previous $5.21 Million 4.32%

% of portfolio

0.12%

Previous 0.14%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $1.19 Million - $1.84 Million	-53,362 Reduced 25.81%	153,389 $4.98 Million
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $4.13 Million - $5.37 Million	195,541 Added 1744.34%	206,751 $5.21 Million
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $111,094 - $147,170	-4,476 Reduced 28.53%	11,210 $364,000
Q3 2023 Nov 14, 2023	SELL	$21.97 - $33.8 $370,787 - $570,442	-16,877 Reduced 51.83%	15,686 $427,000
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $698,150 - $818,959	32,563 New	32,563 $724,000
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $589,981 - $886,007	29,573 New	29,573 $600,000
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $235,289 - $343,498	-13,577 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $135,364 - $206,444	-8,189 Reduced 37.62%	13,577 $306,000
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $372,198 - $508,018	21,766 New	21,766 $431,000
Q3 2021 Nov 15, 2021	SELL	$19.68 - $22.53 $355,125 - $406,553	-18,045 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.97 - $24.43 $50,084 - $61,270	2,508 Added 16.14%	18,045 $397,000
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $289,796 - $377,018	-12,337 Reduced 44.26%	15,537 $370,000
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $467,725 - $760,960	27,874 New	27,874 $729,000
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $658,224 - $1.06 Million	-52,827 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$11.0 - $18.26 $17,072 - $28,339	1,552 Added 3.03%	52,827 $889,000
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $908,262 - $1.26 Million	-89,838 Reduced 63.66%	51,275 $610,000
Q4 2019 Feb 14, 2020	BUY	$12.06 - $16.96 $1.4 Million - $1.96 Million	115,830 Added 458.13%	141,113 $1.71 Million
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $508,830 - $716,566	-48,879 Reduced 65.91%	25,283 $357,000
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $518,408 - $676,369	-53,007 Reduced 41.68%	74,162 $827,000
Q1 2019 May 15, 2019	BUY	$10.03 - $15.71 $749,100 - $1.17 Million	74,686 Added 142.31%	127,169 $1.49 Million
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $103,235 - $157,185	9,144 Added 21.1%	52,483 $701,000
Q3 2018 Nov 01, 2018	BUY	$12.27 - $15.65 $365,879 - $466,667	29,819 Added 220.55%	43,339 $608,000
Q2 2018 Aug 03, 2018	BUY	$15.3 - $19.69 $206,856 - $266,208	13,520 New	13,520 $213,000
Q1 2018 May 07, 2018	SELL	$14.59 - $25.5 $1.25 Million - $2.18 Million	-85,654 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$15.77 - $20.72 $1.35 Million - $1.77 Million	85,654	85,654 $1.55 Million

Others Institutions Holding CORT

# of Institutions

311

Shares Held

88.3M

Call Options Held

1.07M

Put Options Held

973K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.95B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Corcept Therapeutics Inc Transaction History